Cookies

Like most websites The Translational Scientist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

Disease Area

Disease Area Cancer

More than METs the Eye

| Jonathan James

The role of different types of MET mutation in lung cancer could demand a rethink of treatments.

Disease Area Immunology

Just One Shot

| Stephanie Sutton

A vaccine using mRNA demonstrates potential for broad influenza protection.

Disease Area Analytical science

Real-Time Tumor Analysis

| William Aryitey

MALDI and a SpiderMass device could save valuable surgery time

Disease Area Diagnostics & prognostics

Markers for Prognostic Progress

| Ana Robles

Better lung cancer treatment through biomarkers

Disease Area Drug discovery

Go Forth and Find a Flu Vaccine

Bill Gates has issued a challenge to help researchers push for a universal flu vaccine.

Disease Area Drug discovery

Algal Boom

| Andrew Dahl

Algae are bacteria-fight experts. Why aren’t we using them more for drug discovery?

Disease Area Diagnostics & prognostics

Cost-effective Cancer Checks

| William Aryitey

Testing the whole population of women for breast/ovarian cancers mat be more cost-effective than current methods

Disease Area Diagnostics & prognostics

Variant Database Collaborations – for Cancer and Beyond

| Obi Griffith and Heidi Rehm

It's important to research relevant academic papers, but it's equally important to make sure it's still relevant

Disease Area Cancer

Anticipating NRAS Resistance

| William Aryitey

How researchers are unraveling the mystery of melanoma drug resistance

Disease Area Pain & critical care

Hurt Blocker

| James Strachan

Researchers develop a new way to tackle pain: inhibition of RNA-protein interactions

Register to The Translational Scientist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts

Register